Presentation (CTI)

OBJECTIVES: The Saudi Vision 2030 healthcare transformation aims to shift from a volume-based to a value-based system. This study investigates the current perceptions, knowledge, and practical barriers regarding the implementation of Value-Based Healthcare (VBHC) and innovative contracting models from the perspective of key stakeholders in the Saudi pharmaceutical market.
METHODS: A qualitative study was conducted using semi-structured interviews with 18 high-level stakeholders, including Ministry of Health (MoH) decision-makers, senior hospital administrators, and pharmaceutical Market Access Directors. Interviews were transcribed and analyzed via thematic analysis using the Consolidated Framework for Implementation Research (CFIR).
RESULTS: Universal theoretical support for VBHC was observed, but significant implementation barriers were identified across four major themes: (1) Data Infrastructure Deficit: A lack of standardized, integrated real-world data (RWD) systems to track patient outcomes and costs essential for value assessment. (2) Trust and Transparency Gap: Payers expressed concern over commercial agendas, while industry cited a lack of transparent evaluation criteria and procedural predictability. (3) Organizational Inertia: Bureaucratic structures, rigid procurement laws, and short-term annual budget cycles hinder adoption. (4) Skill-Set Shortage: A critical need for specialized training in health economics and commercial negotiation for all parties.

CONCLUSIONS: While strategic motivation for VBHC in Saudi Arabia is high, implementation is hindered by systemic data, trust, and resource barriers. To mature, the Kingdom must prioritize building robust RWD infrastructure and a governance framework that fosters collaborative risk-taking between public payers and industry. This research provides a critical foundation for a localized value-based roadmap.